Many patients who previously used Ozempic for weight loss switch to Tirzepatide for faster and more effective results
Pure osmotic laxatives without bulk-forming fiber have become the preferred standard for managing these specific medication side effects
However, the authors emphasize the need for longer-term studies and trials focused specifically on individuals with binge eating disorder to better understand the full benefits and potential risks of these medications
Produces higher weight loss results than many alternatives Helps with appetite, blood sugar, and fat metabolism Compared to phentermine, tirzepatide is usually more effective but also more complex and long-term
placebo when added to standard of care in 3,297 adults with type 2 diabetes with established CVD for a minimum observation period of two years
Participants who had been on the medication for 36 weeks (average weight loss of 20.9%) were then randomized to continue or switch to placebo